EV-223

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameEV-223
Drug Alias NamerEV-223
ClassificationOther
Mechanisms of ActionTryptase inhibitors
TargetsTryptase
Therapy Area/IndicationsHypersensitivityAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEvolutec
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEvolutec
Active IndicationsN/A
Inactive IndicationsHypersensitivityAsthma

Other Information

ATC CodeN/A
Related LinksN/A